SPDR S&P Pharmaceuticals ETF Rating $47.67 +0.07 (+0.15%) Closing price 04:10 PM EasternExtended Trading$47.55 -0.12 (-0.24%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.69Holdings in XPH have an aggregate rating of Moderate Buy based on 250 analyst ratings issued in the past year covering 25 companies (78.4% of the portfolio).XPH Aggregate Price Target$47.67High Prediction$47.67Average Prediction$47.67Low Prediction$47.67Holdings in XPH have an aggregate price target of $47.67 and a range of $47.67 to $47.67 covering 25 companies (78.4% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.46%TARSTarsus Pharmaceuticals$56.49-0.7%2.2367 of 5 stars2.71$66.67 18.0%7Positive News4.28%ELANElanco Animal Health$18.79-1.3%2.9312 of 5 stars2.78$17.33 -7.8%94.04%VTRSViatris$10.45-0.3%1.7262 of 5 stars1.80$10.40 -0.5%53.82%JNJJohnson & Johnson$177.12-0.6%4.6484 of 5 stars2.65$176.29 -0.5%20Trending News3.62%RPRXRoyalty Pharma$36.50+2.0%4.9826 of 5 stars3.33$48.00 31.5%3Positive News3.58%JAZZJazz Pharmaceuticals$128.53-1.0%4.5941 of 5 stars2.88$178.67 39.0%16Positive News3.50%MRKMerck & Co., Inc.$84.71+0.7%4.9964 of 5 stars2.35$107.44 26.8%20Positive News3.48%PFEPfizer$24.74+0.8%4.8966 of 5 stars2.39$28.12 13.7%18Trending News3.43%CORTCorcept Therapeutics$71.73+0.7%4.8611 of 5 stars3.00$134.50 87.5%53.41%AXSMAxsome Therapeutics$125.68-2.8%4.7504 of 5 stars3.13$177.86 41.5%15Positive NewsInsider Trade3.23%BMYBristol Myers Squibb$47.25+1.1%4.8936 of 5 stars2.24$56.38 19.3%21Trending News3.15%OGNOrganon & Co.$10.37-1.0%4.6543 of 5 stars2.80$17.33 67.2%5News CoveragePositive News3.12%ZTSZoetis$149.80-1.3%4.8806 of 5 stars2.56$200.88 34.1%9Positive NewsAnalyst Forecast2.94%ANIPANI Pharmaceuticals$98.46+3.4%3.9495 of 5 stars3.10$88.25 -10.4%10News CoverageAnalyst Forecast2.87%LLYEli Lilly and Company$749.99+1.5%5 of 5 stars2.70$950.17 26.7%23Trending News2.86%PRGOPerrigo$22.30-0.1%4.9581 of 5 stars2.40$33.00 48.0%5Positive News2.83%HRMYHarmony Biosciences$34.00-5.1%4.5681 of 5 stars3.00$51.00 50.0%10Positive NewsHigh Trading Volume2.71%LQDALiquidia Technologies$27.80-0.6%3.3488 of 5 stars3.00$32.11 15.5%102.70%XERSXeris Biopharma$7.68-1.2%3.4816 of 5 stars2.83$7.08 -7.8%6Positive NewsShort Interest ↓2.58%PBHPrestige Consumer Healthcare$65.98+0.3%4.6006 of 5 stars2.29$93.33 41.5%7Positive News2.43%SUPNSupernus Pharmaceuticals$46.03+0.5%3.3471 of 5 stars2.50$43.00 -6.6%4News CoverageInsider Trade2.42%OCULOcular Therapeutix$12.76+0.4%3.8164 of 5 stars3.00$17.20 34.8%5News Coverage2.41%PCRXPacira BioSciences$26.30-1.6%3.3693 of 5 stars2.71$30.83 17.2%7Positive News2.28%AMRXAMNEAL PHARMACEUTICALS$9.89+1.6%3.6073 of 5 stars3.00$11.60 17.3%5Positive News2.24%AMPHAmphastar Pharmaceuticals$29.33+0.2%3.6623 of 5 stars2.40$31.60 7.7%5Positive News This page (NYSEARCA:XPH) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XPH Stock Alerts